title: Renal sympathetic denervation for resistant hypertension.
abstract: Resistant hypertension is an increasingly prevalent health problem associated with important adverse cardiovascular outcomes. The pathophysiology that underlies this condition involves increased function of both the sympathetic nervous system and the renin-angiotensin II-aldosterone system. A crucial link between these 2 systems is the web of sympathetic fibres that course within the adventitia of the renal arteries. These nerves can be targeted by applying radiofrequency energy from the lumen of the renal arteries to renal artery walls (percutaneous renal sympathetic denervation [RSD]), an approach that has attracted great interest. This paper critically reviews the evidence supporting the use of RSD. Small studies suggest that RSD can produce dramatic blood pressure reductions: In the randomized Symplicity HTN-2 trial of 106 patients, the mean fall in blood pressure at 6 months in patients who received the treatment was 32/12 mm Hg. However, there are limitations to the evidence for RSD in the treatment of resistant hypertension. These include the small number of patients studied; the lack of any placebo-controlled evidence; the fact that blood pressure outcomes were based on office assessments, as opposed to 24-hour ambulatory monitoring; the lack of longer-term efficacy data; and the lack of long-term safety data. Some of these concerns are being addressed in the ongoing Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-3) trial. The first percutaneous RSD system was approved by Health Canada in the spring of 2012. But until more and better-quality data are available, this procedure should generally be reserved for those patients whose resistant hypertension is truly uncontrolled.
authors.affiliation: Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada. mfroeschl@ottawaheart.ca
authors.forename: Michael
authors.initials: M
authors.lastname: Froeschl
authors.forename: Adnan
authors.initials: A
authors.lastname: Hadziomerovic
authors.forename: Marcel
authors.initials: M
authors.lastname: Ruzicka
mesh_terms: D002170:Canada; D003329:Coronary Vasospasm / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D006973:Hypertension / Q000503:physiopathology / Q000601:surgery*; D012077:Renal Artery / Q000294:innervation*; D013562:Sympathectomy; D013564:Sympathetic Nervous System / Q000601:surgery*